Application 091008
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 100MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 300MG | No | No |
| 003 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091008-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A091008-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | b86c81d9-9a4a-4847-be18-520e5cc5dc4b | 2025-12-12 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | JVET PHARMACEUTICALS LLC | 63a5fc6d-ca57-4726-b70d-805ac023d959 | 2025-12-10 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Glenmark Pharmaceuticals Inc., USA | 3865a6e3-112c-490c-82ac-35401336b16e | 2025-12-05 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 021329d0-7d32-4fd8-81bf-a8b0d8b49e43 | 2025-12-04 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Redpharm Drug | 44f2b497-55b2-864f-e063-6294a90ad6d5 | 2025-12-02 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 4470a567-93a6-a293-e063-6394a90affc1 | 2025-11-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b74a427c-9cc1-4b15-9ed2-cc891741fe67 | 2025-11-19 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | bec31452-b52b-4698-ba4c-0b614780ee84 | 2025-11-12 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Acella Pharmaceuticals, LLC | 3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2 | 2025-11-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 5134369d-c7f6-4569-a425-d50e5a5d694f | 2025-10-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 47a22de2-ec66-45be-8648-89ed3ab6e67e | 2025-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 25befbfa-5125-4363-8306-f862e81c0a6f | 2025-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d9d78138-e1e9-4107-9099-4910cb1422d8 | 2025-10-22 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 6e900fc4-a2b3-411f-9ab7-8dcbb97b697b | 2025-10-16 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | aa246838-609c-4254-a8ec-d6f463a17960 | 2025-10-16 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | efb86e22-5a84-4b33-aad0-71dd5a2c6c8f | 2025-10-13 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 1ead7343-ab25-41b5-af4f-f903470e1dd9 | 2025-10-10 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 781b0d62-a760-4371-8908-1f61329928a6 | 2025-10-10 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | STALLION LABORATORIES PRIVATE LIMITED | b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9 | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | American Health Packaging | bbfdedd7-2baf-4bc6-be59-548a5cf21752 | 2025-10-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |